Patients in most countries of the world do not have access to basic cancer medicines, according to new research from King's College London Global Oncology Group Professor Richard Sullivan and collaborators at Kingston University and the World Health Organization. Their paper, published in The Lancet Oncology, asked oncologists worldwide to list the most important cancer medicines and to describe whether patients could access these medicines in their home country.

The World Health Organization has updated and released an Essential Medicines List every two years since 1977. This list helps policy makers worldwide prioritize which medicines to provide for patients.

Know more: https://www.sciencedaily.com/releases/2021/09/210921125121.htm

• Tags:
• News